We are live on ! Find out more
XBIT icon

XBiotech
XBIT

38 hedge funds and large institutions have $8.61M invested in XBiotech in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 13 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

1.02% less ownership

Funds ownership: 9.06% → 8.03% (-1%)

7% less funds holding

Funds holding: 41 → 38 (-3)

8% less capital invested

Capital invested by funds: $9.39M → $8.61M (-$779K)

38% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 13

50% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 6

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $37K

Holders
38
Holders Change
-3
Holders Change %
-7.32%
% of All Funds
0.61%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
8
Reduced
13
Closed
6
Calls
–
Puts
$37K
Net Calls
-$37K
Net Calls Change
-$44K

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$142K
2
Citadel Advisors
Citadel Advisors
Florida
+$32.2K
3
Northern Trust
Northern Trust
Illinois
+$12K
4
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
+$4K
5
BlackRock
BlackRock
New York
+$3.71K

Top Sellers

Rank Fund Capital Flow
1
OMC
Oasis Management Company
Cayman Islands
-$481K
2
Man Group
Man Group
United Kingdom
-$183K
3
Renaissance Technologies
Renaissance Technologies
New York
-$182K
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$52.8K
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$50K
Name Holding Trade Value Shares
Change 		Change in
Stake
SF
26
Synovus Financial
Georgia
$40.7K – – –
Charles Schwab
27
Charles Schwab
California
$36.1K – – –
LFM
28
LGT Fund Management
Liechtenstein
$34.5K – – –
UBS Group
29
UBS Group
Switzerland
$17.4K -$3.22K -864 -15%
Royal Bank of Canada
30
Royal Bank of Canada
Ontario, Canada
$8K +$1.69K +453 +23%
BNP Paribas Financial Markets
31
BNP Paribas Financial Markets
France
$5.08K +$4K +1,073 +268%
ME
32
McIlrath & Eck
Washington
$2.6K – – –
FCG
33
Financial Connections Group
California
$1K – – –
TRCT
34
Tower Research Capital (TRC)
New York
$1K +$242 +65 +38%
TWC
35
TD Waterhouse Canada
Ontario, Canada
$928 +$745 +200 New
Wells Fargo
36
Wells Fargo
California
$421 +$7 +2 +2%
Osaic Holdings
37
Osaic Holdings
Arizona
$173 -$1.12K -300 -86%
OMC
38
Oasis Management Company
Cayman Islands
– -$481K -137,174 Closed
D.E. Shaw & Co
39
D.E. Shaw & Co
New York
– -$52.8K -15,052 Closed
HF
40
HRT Financial
New York
– -$46K -13,279 Closed
TI
41
Trexquant Investment
Connecticut
– -$45.6K -12,985 Closed
IA
42
IFP Advisors
Florida
– -$1K -200 Closed
Simplex Trading
43
Simplex Trading
Illinois
– +$317 +85 New
1
2

XBIT Hedge Fund Activity: Q1 2023 in Review

38 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in XBiotech (XBIT) for Q1 2023, worth a combined $8.61M — down 8.3% from $9.39M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of XBIT and 3 opened new positions — a net loss of 3 holders — while 13 trimmed existing stakes and 8 added.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $142K. The largest seller was Oasis Management Company, exiting entirely with an estimated $481K sold.

  • 38 institutional investors held XBiotech (XBIT) as of Q1 2023, down from 41 in Q4 2022.
  • Funds reported $8.61M of XBiotech stock for Q1 2023, down 8.3% quarter-over-quarter.
  • 3 funds opened new XBiotech positions in Q1 2023 and 6 closed out, a net change of -3 holders.
  • The largest XBiotech buyer in Q1 2023 was Susquehanna International Group, an estimated $142K added.
  • The largest XBiotech seller in Q1 2023 was Oasis Management Company, an estimated $481K sold.

Based on aggregated 13F filings for Q1 2023.